Early research (Phase 1)Study completedNCT01280175What this trial is testingFoster With or Without Charcoal Block or Aerochamber PlusWho this might be right forHealthy Volunteers Chiesi Farmaceutici S.p.A. 13
Early research (Phase 1)Study completedNCT00063843What this trial is testingAnthrax-rPA: Safety, Tolerability, ImmunogenicityWho this might be right forAnthrax National Institute of Allergy and Infectious Diseases (NIAID) 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT02177721What this trial is testingClinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure ScenarioWho this might be right forInfections, Bacterial Emergent BioSolutions 100
Early research (Phase 1)Study completedNCT01867957What this trial is testingEfficacy and Safety of Anthrax Vaccine, GC1109Who this might be right forAnthrax Seoul National University Hospital 20
Not applicableStudy completedNCT01653392What this trial is testingBioThrax® (Anthrax) Vaccine in Pregnancy RegistryWho this might be right forPregnancy ComplicationsPregnancy OutcomeCongenital Abnormalities Emergent BioSolutions 98
Early research (Phase 1)Study completedNCT00138411What this trial is testingMonoclonal Antibody for Treatment of Inhalation AnthraxWho this might be right forBacillus Anthracis (Anthrax) National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT01263691What this trial is testingSafety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy AdultsWho this might be right forBacillus Anthracis (Anthrax) Infection Emergent BioSolutions 105
Early research (Phase 1)Study completedNCT01952444What this trial is testingSafety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult VolunteersWho this might be right forInhalational Anthrax Elusys Therapeutics 40
Early research (Phase 1)Study completedNCT01979406What this trial is testingAscending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate VaccinesWho this might be right forAnthrax Infection Emergent BioSolutions 120
Very early researchStudy completedNCT04204772What this trial is testingA Pilot Feasibility Study of Activated Charcoal in Healthy VolunteersWho this might be right forHealthy Adult Volunteers Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT01265745What this trial is testingDose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal SubjectsWho this might be right forAnthrax PharmAthene, Inc. 28
Not applicableEnded earlyNCT05672875What this trial is testingEvaluation of the SRI B. Anthracis Lethal Factor Diagnostic SystemWho this might be right forAnthrax SRI International 343
Not applicableNot Yet RecruitingNCT03569553What this trial is testingA Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax PatientsWho this might be right forInhalational Anthrax Emergent BioSolutions 100
Post-approval studies (Phase 4)Study completedNCT01641991What this trial is testingAssessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA ScheduleWho this might be right forBacillus Anthracis (Anthrax) National Institute of Allergy and Infectious Diseases (NIAID) 328
Not applicableStudy completedNCT00123396What this trial is testingVHA Clinicians and Bioterror Events: Interactive Web-based LearningWho this might be right forSmallpoxAnthrax US Department of Veterans Affairs 15
Large-scale testing (Phase 3)Study completedNCT01491607What this trial is testingImmunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy AdultsWho this might be right forAnthrax Emergent BioSolutions 200
Early research (Phase 1)Study completedNCT02655549What this trial is testingAnthrax Vaccines Px563L and RPA563 in Healthy Adult SubjectsWho this might be right forAnthrax Pfenex, Inc 54
Early research (Phase 1)Study completedNCT01932437What this trial is testingIntramuscular Dose-Escalation Study With ETI-204 in Adult VolunteersWho this might be right forInhalational Anthrax Elusys Therapeutics 36
Early research (Phase 1)Study completedNCT02239172What this trial is testingPA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax VaccineWho this might be right forAnthrax Fraunhofer, Center for Molecular Biotechnology 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07201311What this trial is testingCombined Gastrointestinal Decontamination in Acute Severe PoisoningWho this might be right forSevere Poisoning With Cardiotropic or Psychotropic DrugAdmission to Intensive Care Assistance Publique - Hôpitaux de Paris 200